Stockreport

IN8bio's INB-200 Demonstrates Extended Progression-Free Survival in Patients with Newly Diagnosed Glioblastoma [Yahoo! Finance]

IN8bio, Inc.  (INAB) 
PDF Most patients exceeded the expected median PFS based on age and tumor status; two patients from Cohort 2 remain alive beyond two years Additional enrolled patients aw [Read more]